The American Collegiate Athletic Association (NCAA) recommends removing cannabis from the list of banned substances
Last week, the National Collegiate Athletic Association (NCAA) on Competitive Safeguards and Medical Aspects of Sport (CMAS) has recommended removing cannabis from its list of banned substances, calling instead for a «robust educational strategy».
The sports association, which organizes the athletic programs of many of America's leading colleges and universities, first announced its plans for these reforms in June. Some American sports federations like the NBA, MMA or MLB already no longer screen for cannabis.
The committee concluded that removing cannabis from its testing protocols :
- recognizes the ineffectiveness of existing policy, which includes prohibition, testing and penalization
- affirms the role of the NCAA drug-testing program in addressing only performance-enhancing substances
- and stresses the importance of moving towards a harm reduction strategy that prioritizes education and support at school level over penalties.
In a statement, James Houle, chairman of the commission and chief sports psychologist at Ohio State, said that «when it comes to making a decision on something as important as this, we agree that members should have the opportunity to vote on the final outcome.».
«We recommend a radical paradigm shift when it comes to cannabinoids. We want to modernize the strategy with the latest research to give schools the best opportunity to support the health of student-athletes,» said James Houle in a press release.
The NCAA said the recommendation «aims to refocus the health of student-athletes while recognizing members» opinions and the changing cultural and legal landscapes surrounding cannabinoids« and is »based on extensive study informed by industry and subject matter experts," including physicians and addiction experts.
In 2022, CMAS raised the cannabinoid thresholds for failing a test from 35 to 150 nanograms per milliliter of blood, thus aligning itself with on World Anti-Doping Agency policies.
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Business4 weeks ago
The British medical cannabis market is expected to exceed 140,000 patients by 2026
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange


You must be logged in to post a comment Login